July 17, 2024
Testosterone replacement therapy: Not just a guy thing
If you thought testosterone was only a male hormone, you would be mistaken.
July 17, 2024
Magic potion potential? Let’s talk about methylene blue
What if you were told a drug that had been around for 100 years acts as a potent antioxidant, improves mitochondrial and cognitive function and mood, and has anti-microbial, anti-inflammatory, and neuroprotective effects?
July 16, 2024
Did you get your Compounding Pharmacy Snapshot?
If you haven’t already, don’t forget to download and share the 2023-2024 edition of our Snapshot of Pharmacy Compounding in America.
July 16, 2024
After report, FTC to sue PBMs
On Tuesday, the Federal Trade Commission released a scathing, two-years-in-the-making report about PBMs.
July 16, 2024
Yes, we know about the NPR story
Several members have contacted us about a story that ran on NPR’s Morning Edition about a pharmacy in Texas that compounded the chemical used for lethal injections.
July 16, 2024
GLP-1s: A California clarification of sorts
We’ve been bugging the California Board of Pharmacy (politely!) for a while, trying to get a statement on its position and enforcement posture regarding the compounding of FDA-approved drugs that are currently in shortage.
July 15, 2024
Can’t trust that day?
The Mamas and the Papas said you can’t trust Mondays, but that’s not always true. You can count on two things happening today, July 15. Whether you take advantage of them is up to you — but I hope you do.
July 10, 2024
Released: Compounding Pharmacy Snapshot
APC has just released the 2023–2024 edition of our Compounding Pharmacy Snapshot — a slick overview of the practice of pharmacy compounding in the US of A.
July 10, 2024
EduCon countdown: 6 days to go
Take our July 15 session (really, you should take it) where APC’s Tenille Davis is covering two of today’s critical topics: Best practices in both ketamine and GLP-1 compounding.
July 10, 2024
Coming quickly: Compounders converge on capitol
Registration is open for Compounders on Capitol Hill! If you’re planning to attend, the sooner you register the better because we’re starting to schedule visits with legislators, and we want to be sure you’re included.
July 3, 2024
APC best practices presented at ketamine forum
APC CEO Scott Brunner and PCCA’s A.J. Day attended a forum in Washington, D.C., on the emergence of ketamine as an area of therapeutic interest.
July 3, 2024
APC weighs in with several state BOPs
APC is always keeping track of what state boards of pharmacy are up to, and we’ll reach out when we think something needs clarification. Here’s a sampling of the kind of letters we’ve sent recently.
July 3, 2024
Success: Town hall briefing on GLP-1 compounding
We blasted through our expectations for our virtual town hall on compounding semaglutide on June 26, with almost 700 people registered.
July 3, 2024
APC delivers compounding briefing on Capitol Hill
APC briefed about four dozen House of Representatives healthcare staffers on the practice of pharmacy compounding — and cleared some of the muddied waters.
June 25, 2024
Those Lilly letters
We learned this week that several compounding pharmacies have received a cease-and-desist letter from a law firm representing Eli Lilly.
June 16, 2024
When media does its job
Well check this out: A news story about compounded GLP-1s that’s actually accurate, sans all the usual hand-wringing and fear-mongering.
June 16, 2024
The cover of the Rolling Stone?
Okay, not quite the cover, but APC has certainly been quoted in that and dozens of other publications over the past several months as the GLP-1 phenomenon has shone a bright light on pharmacy compounding.
June 16, 2024
GLP-1 misinfo affects you — here’s what to do about it
Learn what’s at stake and what APC is doing about it — and how you can help … even if you don’t compound GLP-1s.
June 16, 2024
FDA listened, we spoke
The FDA held a listening session on the "Use and Processes of Advisory Committees" on Thursday. APC's Tenille Davis and PCCA's AJ Day were there.
June 7, 2024
How does this protect patients?
In comments submitted earlier this week, APC took issue with provisions of proposed new compounding regulations from the California Board of Pharmacy.
June 7, 2024
Tampa with us: It’s next Wednesday
APC will be in Tampa next Wednesday, June 12 for a CompoundED UpDATE regional meeting, made possible by a grant from PCCA. Also, Topi-CLICK is sponsoring an APC ‘Compounder Get-Together” in Boston on the evening of June 18.
June 7, 2024
Ketamine? GLP-1s? We’ve got tips for you
We’re less than six weeks from EduCon 2024, APC’s hot-topics-and-best-practice webinar series for compounding pharmacists and technicians.
June 7, 2024
We need to talk.
Why? Because the current misinformation about compounding – particularly compounded GLP-1s – is a hairball that the media can’t seem to cough up.
June 6, 2024
Compounded sublingual semaglutide: It isn’t a copy
APC has created a one-pager explanation for you to share.
June 6, 2024
Correcting compounding confusion
APC sent a letter to the Mississippi medical board this week sharing information to help them better understand compounding and the framework in which compounding of GLP-1 drugs occurs.
June 6, 2024
Acadiana Plastics Molding joins APC as Bronze-level supporter
Acadiana Plastics has committed as a Bronze-level Corporate Patron, a $10,000 investment.
June 6, 2024
Calling all veterinary compounders
If a significant percentage of your business is veterinary compounding, we want your input.
May 30, 2024
Technicians: Don’t miss this opportunity
The Pharmacy Compounding Foundation is awarding up to 10 pharmacy technicians a grant valued at $495 to complete APC’s online 15-hour curriculum, The Ethical, Legal, and Regulatory Foundations of Pharmacy Compounding.
May 30, 2024
New APC issue brief on OTC compounding
We’ve released a new issue brief on over-the-counter compounding.
May 30, 2024
WSJ podcast features compounding and APC
This Wall Street Journal podcast, the second in a four-part series WSJis doing on GLP-1s, features APC CEO Scott Brunner (well, briefly).
